Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women

CMAJ

Volumn 187, Issue 9, 2015, Pages 648-656

  Singh, Namisha ^a   Gandhi, Sonja ^a,b   McArthur, Eric ^a,c   Moist, Louise ^a,b,c   Jain, Arsh K ^a,c   Liu, Aiden R ^a,b   Sood, Manish M ^d   Garg, Amit X ^a,b  

^a Division of Nephrology   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; NORFLOXACIN; ANTIINFECTIVE AGENT; URINARY TRACT ANTIINFECTIVE AGENT;

AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; DRUG USE; EMERGENCY WARD; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINARY TRACT INFECTION; AGE; COMPLICATION; KIDNEY FAILURE; SEX DIFFERENCE; TREATMENT FAILURE; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CIPROFLOXACIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; NITROFURANTOIN; NORFLOXACIN; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT FAILURE; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; URINARY TRACT INFECTIONS;

EID: 84932182194     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.150067     Document Type: Article

References (28)

1. Harding GKM, Ronald AR. The management of urinary infections: What have we learned in the past decade? Int J Antimicrob Agents 1994;4:83-8.
2. Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Arch Intern Med 2006; 166:635-9.
3. Conklin JD. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother 1978;25:233-52.
4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.
5. Sachs J, Geer T, Noell P, et al. Effect of renal function on urinary recovery of orally administered nitrofurantoin. N Engl J Med 1968; 278:1032-5.
6. Felts JH, Hayes DM, Gergen JA, et al. Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency. Am J Med 1971;51:331-9.
7. Repchinsky C, editor-in-chief. Compendium of pharmaceuticals and specialties: the Canadian drug reference for health professionals. 47th ed. Ottawa: Canadian Pharmacists Association; 2012.
8. Oplinger M, Andrews CO. Nitrofurantoin contraindication in patients with a creatinine clearance below 60mL/min: looking for the evidence. Ann Pharmacother 2013;47:106-11.
9. Bains A, Buna D, Hoag NA. A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment. Can Pharm J 2009;142:248-52.
10. Geerts AF, Eppenga WL, Heerdink R, et al. Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care. Eur J Clin Pharmacol 2013;69:1701-7.
11. Farag A, Garg AX, Li L, et al. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis. Am J Kidney Dis 2014;63:422-8.
12. Population by sex and age group, by province and territory (number, both sexes). Ottawa: Statistics Canada; 2013. Available: www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo31a-eng.htm (accessed 2014 July 15).
13. Levy AR, O'Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003;10:67-71.
14. Fleet JL, Weir MA, McArthur E, et al. Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. Am J Kidney Dis 2014;64: 883-91.
15. Tawadrous D, Dixon S, Shariff SZ, et al. Altered mental status in older adults with histamine2-receptor antagonists: a population-based study. Eur J Intern Med 2014;25:701-9.
16. Zhao YY, Weir MA, Manno M, et al. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med 2012;156:560-9.
17. Dev V, Dixon SN, Fleet JL, et al. Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study. BMC Nephrol 2014;15:79.
18. Gandhi S, Fleet JL, Bailey DG, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013;310:2544-53.
19. Fleet JL, Dixon SN, Shariff SZ, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol 2013;14:81.
20. Barclay L. New guidelines for management of urinary tract infection in nonpregnant women. New York: Medscape Medical News; 2008. Available: www.medscape.org/viewarticle/571545 (accessed 2014 July 8). Registration required to access content.
21. Matzke GR, Aronoff GR, Atkinson AJ Jr, et al. Drug dosing consideration in patients with acute and chronic kidney disease - a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:1122-37.
22. Daneman N, Gruneir A, Newman A, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother 2011;66:2856-63.
23. Banerjee R, Johnston B, Lohse C, et al. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013;34:361-9.
24. Henriksen DP, Nielsen SL, Laursen CB, et al. How well do discharge diagnoses identify hospitalised patients with community-acquired infections? A validation study. PLoS ONE 2014;9:e92891.
25. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Comm Stat Simul Comput 2009;38:1228-34.
26. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005;330:960-2.
27. McIsaac WJ, Mazzulli T, Permaul J, et al. Community-acquired antibiotic resistance in urinary isolates from adult women in Canada. Can J Infect Dis Med Microbiol 2006;17:337-40.
28. Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003;349:259-66.